Myeloma-specific biomarkers

Myeloma-specific biomarkers are biological signs used to detect and monitor multiple myeloma, a type of blood cancer involving plasma cells. These markers include abnormal proteins like monoclonal proteins (M-proteins) found in blood or urine, and genetic changes in myeloma cells. They help doctors diagnose the disease, assess how aggressive it is, and track its response to treatment. Identifying these biomarkers allows for more precise management of the condition, enabling personalized treatment plans and early detection of relapse, ultimately improving patient outcomes.